Lymphangitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Signs and symptoms]]

Revision as of 19:38, 9 June 2015

Lymphangitis Microchapters

Home

Overview

Historical Perspective

Classification

Causes

Pathophysiology

Differentiating Lymphangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Lymphangitis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangitis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangitis differential diagnosis

CDC on Lymphangitis differential diagnosis

Lymphangitis differential diagnosis in the news

Blogs on Lymphangitis differential diagnosis

Directions to Hospitals Treating Lymphangitis

Risk calculators and risk factors for Lymphangitis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]

Overview

The presentation of red streaks on the skin in lymphangitis can also be a presentation of conditions such as contact dermatitis, cellulitis, thrombophlebitis, fasciitis and myositis. Clinical findings like red linear streaks proximal to a distal site of infection, tender regional lymphadenopathy and fever, along with a history suggestive of infection by causative organisms of lymphangitis helps in differentiating lymphangitis from other conditions.

Differentiating Lymphangitis from other Diseases

  • Contact dermatitis: Contact dermatitis is characterized by onset of symptoms like itching, burning and pain within minutes to hours following exposure to an environmentally relevant allergen and is associated with clinical findings like macular erythema, fissures, or vesicles. Clinical evidences like distal site of infection and tender regional lymphadenopathy are absent.
  • Myositis: Typical cutaneous lesions along with symmetric proximal muscle weakness, elevated serum muscle enzymes, electromyographic finding of myopathic changes, and characteristic muscle biopsy abnormalities are characteristic of myositis.[1]
  • Necrotizing fasciitis: Gradual in onset and later rapid in progression of clinical features like fever, pain, swelling, crepitus, and foul-smelling wound drainage following trauma, surgery, or spread of an infection from a near by tissue or organ, along with signs of systemic toxicity and elevated serum creatine kinase levels are suggestive of necrotizing fasciitis. Surgical exploration establishes the diagnosis.[2]
  • Septic thrombophlebitis: Septic thrombophlebitis presents with clinical manifestations like fever, erythema, tenderness and purulent drainage at the site of an involved vessel in the setting of an intravascular catheter and persistent bacteremia. Further laboratory studies and radiological evidence establishes the diagnosis and differentiates it from lymphangitis.[3]
  • Superficial thrombophlebitis: Clinical findings like erythema, tenderness, induration, or palpable nodular cords along the course of a superficial vein is suggestive of superficial thrombophlebitis. Further evaluation with duplex ultrasound or laboratory studies helps in establishing the diagnosis while differentiating it from lymphangitis.[4]

References

  1. Bohan A, Peter JB (1975). "Polymyositis and dermatomyositis (second of two parts)". N Engl J Med. 292 (8): 403–7. doi:10.1056/NEJM197502202920807. PMID 1089199.
  2. Majeski J, Majeski E (1997). "Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment". South Med J. 90 (11): 1065–8. PMID 9386043.
  3. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP; et al. (2009). "Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America". Clin Infect Dis. 49 (1): 1–45. doi:10.1086/599376. PMID 19489710.
  4. Samlaska CP, James WD (1990). "Superficial thrombophlebitis. II. Secondary hypercoagulable states". J Am Acad Dermatol. 23 (1): 1–18. PMID 2195069.

Template:WH Template:WS